Company Search:
Advanced Search
Sponsored Links
Mesoblast Ltd Company Snapshot
Mesoblast Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd with three other companies in this sector in AUSTRALIA : Medlab Clinical Ltd (2021 sales of 6.69 million Australian Dollars [US$4.85 million] of which 55% was Corporate/ Other), Cellmid Limited (5.82 million Australian Dollars [US$4.21 million] of which 75% was Advangen Japan), and Paradigm Biopharmaceuticals Ltd (8.94 million Australian Dollars [US$6.48 million] of which 100% was Research and development of pharmaceutic).

Sales Analysis. Sales fell dramatically in 2021: During the year ended June of 2021, sales at Mesoblast Ltd were A$9.98 million (US$7.23 million). This is a sharp decrease of 79.2% versus 2020, when the company's sales were A$47.97 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Mesoblast Ltd
  Stock Performance Chart for Mesoblast Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/24/2021): 1.72
(Figures in Australian Dollars)
1 Week 4.9%   13 Weeks -12.9%  
4 Weeks -20.4%   52 Weeks -65.0%  
Mesoblast Ltd Key Data:
  Ticker: MSB Country: Australia
  Exchanges: OTC BLN ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2021 Sales 9,980,303
(Year Ending Jan 2022).
Employees: 83
  Currency: Australian Dollars Market Cap: 1,114,429,430
  Fiscal Yr Ends: June Shares Outstanding: 647,924,087
  Share Type: Ordinary Closely Held Shares: 92,118,639
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.